Fight Over Waze? Way
Health Care: Health Services
Alere Inc (ALR: NYSE)
$25.54 -0.50 | -1.92%
05/24/13 - 10:31 AM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 26.04 |
| 52 Week High | 29.57 |
| 52 Week Low | 17.13 |
| Avg. Daily Vol. (Mil) | 0.67 |
| Beta (3 year) | 2.20 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,116.75 |
| Shares Out (Mil) | 81.29 |
| Float (Mil) | 67.13 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.20 |
| Current Ratio | 2.10 |
| LT Debt/ Equity | 2.51 |
| Total Debt / Equity | 2.55 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.73 |
| Price/Book | 1.40 |
| Price/Cash Flow | 5.80 |
| Per Share Data | |
| Earnings | -1.09 |
| Sales | 35.51 |
| Book Value | 18.65 |
| Cash Flow | 4.51 |
| Business Summary | |
|---|---|
| Alere Inc enables individuals to take charge of improving their health and quality of life at home. Its products and services focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. | |
| General Information | |
| 51 Sawyer Road
Suite 200 Waltham, MA 02453 |
|
| www.alere.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 17400 | |
| CEO: Ron Zwanziger | |
| Short Interest | |
| Current Month (Mil) | 4.00 |
| Previous Month (Mil) | 3.95 |
| Short Interest Ratio (Days) | 5.90 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -0.90 |
| Return on Investments | -1.10 |
| Profitability | |
| Gross Margin | 65.60 |
| EBIT Margin | 6.50 |
| Profit Margin | -2.30 |
Portfolios with ALR
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ProPrivate Capital Management
- Contributor7 U.S. Stock Picks for 2012...
- Contributor3 Health Care Stocks That C...
- ProManning & Napier Advisors
- User30 or Less
- ContributorNew Year's Short Squeeze Op...
Latest ALR Headlines from TheStreet
- 4 Health Care Stocks Rising on Major Volume 10.03.12 | 02:10 pm
- Analysts' Actions: AAPL V KSS PHM AMGN 09.12.12 | 09:09 am
- Alere's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.08.12 | 02:08 pm
- Alere Stock Hits New 52-Week Low (ALR) 06.25.12 | 02:06 pm
- Alere Inc (ALR): Today's Featured Health Services Winner 05.18.12 | 05:05 pm
- Alere Stock Gaps Down On Today's Open (ALR) 05.11.12 | 08:05 am
- Analysts' Actions: AEO, ANF, COST, HOLX 05.01.12 | 08:05 am
- Alere's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.30.12 | 02:04 pm
- Alere's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.08.12 | 01:02 pm
- 7 U.S. Stock Picks for 2012 From Addison Capital 12.07.11 | 11:12 am
Press Releases for ALR
- Alere To Attend Goldman Sachs 34th Annual Global Healthcare Conference On June 13th - PR Newswire 05.23.13 | 04:05 pm
- Alere To Attend Jefferies 2013 Global Healthcare Conference On June 4th - PR Newswire 05.23.13 | 04:05 pm
- Alere Inc. Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock - PR Newswire 05.16.13 | 04:05 pm
- Alere Inc. Announces Pricing Of Senior Subordinated Notes Offering - PR Newswire 05.13.13 | 05:05 pm
- Alere Inc. Announces Offering Of $425 Million Of Senior Subordinated Notes - PR Newswire 05.13.13 | 06:05 am
- Alere Inc. Announces Tender Offer And Consent Solicitation For Any And All Of Its 9.00% Senior Subordinated Notes Due 2016 - PR Newswire 05.10.13 | 11:05 pm
- Alere Inc. Schedules Conference Call For 8:30 A.m. ET May 9, 2013 To Discuss First Quarter 2013 Results - PR Newswire 05.02.13 | 08:05 am
- Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign - PR Newswire 04.25.13 | 09:04 am
- Pilot Study Demonstrates Home BNP Testing Is Feasible & Suggests Home Monitoring May Have Value In Guiding Therapy For High-Risk Patients - PR Newswire 04.23.13 | 09:04 am
- Alere To Launch "Test Target Treatâ¿¢" Campaign At 9th Annual International Symposium On Antimicrobial Agents And Resistance - PR Newswire 03.13.13 | 08:03 am
Partner Headlines for ALR
- Alere Tops Estimates in 3Q - Analyst Blog - Zacks 11.14.12 | 09:11 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 10.08.12 | 09:10 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 10.03.12 | 09:10 am
- Abaxis Expands Vet Product Line - Analyst Blog - NASDAQ 09.21.12 | 02:09 pm
- Abaxis Expands Vet Product Line - Analyst Blog - Zacks 09.21.12 | 10:09 am
- 5 Undervalued Healthcare Stocks That Analysts Love - Seeking Alpha 08.29.12 | 09:08 am
- Pre-Market Earnings Report for July 25, 2012 : BMY, BA, ALXN, ARMH, ARG, ATI, AOL, BKU, AVX, ALR, MT, ATMI - NASDAQ 07.24.12 | 08:07 pm
- Must Know Stock Upgrades and Downgrades Today - Wall St. Cheat Sheet 05.24.12 | 03:05 am
- Diagnostics Firm Crushes Earnings Estimates And Is Heading Higher - Seeking Alpha 04.30.12 | 09:04 am
- Alere's Flu Test Gains FDA Waiver - Analyst Blog - Zacks 01.27.12 | 05:01 pm
